Results 111 to 120 of about 404,283 (311)

Cross-sectional study on the epidemiological investigation ability of professional staff from Centers for Disease Control and Prevention in Guizhou Province

Frontiers in Public Health
IntroductionThis study aims to evaluate the qualifications and identify skill enhancement areas for epidemiological investigators in Centers for Disease Control and Prevention (CDCs) in Guizhou’s, informing future training and policy initiatives to ...
He Huang, Guang-hai Yao, Jiao Huang, Bin Deng, Jun Wu, Chun Yu   +5 more
doaj   +1 more source

Plasma EV Proteomics Identifies ECM Remodeling and Inflammatory Proteins LUM and C7 as Candidate Biomarkers in FSHD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral muscular dystrophy (FSHD) is one of the most debilitating and common muscular dystrophies. Despite its severity, no approved therapy exists for FSHD patients. However, several therapeutic candidates are currently under development, and some have recently entered clinical trials, marking the need for reliable ...
Mustafa Bilal Bayazit, Chiranth K. Nagaraj, Jackson S. Newell, Kim Truc Nguyen, Xilal Y. Rima, Jacob Doon‐Ralls, Eduardo Reátegui, Jeffrey M. Statland, Rabi Tawil, Kevin M. Flanigan, Scott Q. Harper, Nizar Y. Saad   +11 more
wiley   +1 more source

CDC bulletin, vol. IX, no. 6, June 1950 [PDF]

Center highlights: Administrative, Audio-Visual Production, Engineering, Entomologic, Laboratory, Technical Development, Training, Veterinary Public Health -- CDC training courses--Morbidity data.Federal Security Agency, Public Health Service ...

core  

Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito, Kamal Benguerba, Ken Tsuchida, Kazushige Yazawa, Isao Tsumiyama, Hiromitsu Kayama, Sandra P. Reyna, Farid Khan, Richard S. Finkel   +8 more
wiley   +1 more source

CDC bulletin, Jan., Feb., Mar., 1947 [PDF]

The Communicable Disease Center is a field station of the States Relations Division in the Bureau of States Services of the U. S. Public Health Service.

core  

Impact of drink-driving penalty enhancement policies on road traffic injury deaths among vulnerable road users in Shandong Province: an interrupted time series study

BMC Public Health
Background  Road traffic injuries (RTIs) rank as the seventh leading cause of death in China, with over 70% of these fatalities involving vulnerable road users (VRUs). In 2011, the Chinese government revised and implemented a new road traffic safety law,
Zehan Zhang, Zilong Lu, Wengui Zheng, Xianxian Chen, Jing Dong, Jie Ren, Haiyan Liu, Te Yang, Xiaolei Guo, Jie Chu   +9 more
doaj   +1 more source

Pasteurella multocida strains of a novel capsular serotype and lethal to Marmota himalayana on Qinghai-Tibet plateau in China

International Journal of Medical Microbiology
Pasteurella multocida is a zoonotic pathogen causing serious diseases in humans and animals. Here, we report P. multocida from wildlife on China's Qinghai-Tibet plateau with a novel capsular serotype, forming a single branch on the core-genome ...
Ran Duan, Dongyue Lyu, Shuai Qin, Junrong Liang, Wenpeng Gu, Qun Duan, Weiwei Wu, Deming Tang, Haonan Han, Xiaojin Zheng, Jinxiao Xi, Asaiti Bukai, Xinmin Lu, Peng Zhang, Dan Zhang, Meng Xiao, Huaiqi Jing, Xin Wang   +17 more
doaj   +1 more source

Neurochemical Endpoints to Inform Early‐Stage Trials of Spinocerebellar Ataxia 2 and 3 in a Multisite Setting

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neurochemical levels measured by brain MR spectroscopy (MRS) have been proposed as endpoints for clinical trials in early‐stage spinocerebellar ataxia (SCA) trials. We tested their trial‐readiness by quantifying neurochemicals in three affected brain regions in early‐stage cohorts of SCA2 and SCA3, examining their reproducibility in ...
James M. Joers, Yaqiao Wei, Dinesh K. Deelchand, Adam Berrington, Young Woo Park, Guita Banan, Michal Povazan, Jens T. Rosenberg, André J. W. van der Kouwe, Tetsuo Ashizawa, Khalaf O. Bushara, Chiadi U. Onyike, Sub H. Subramony, Jeremy D. Schmahmann, Brian J. Soher, Peter B. Barker, Thomas H. Mareci, Eva‐Maria Ratai, Lynn E. Eberly, Gülin Öz   +19 more
wiley   +1 more source

CDC bulletin, Oct. Nov. Dec. 1946 [PDF]

The Communicable Disease Center is a field station of the States Relations Division in the Bureau of States Services of the U. S. Public Health Service.

core  

China Stroke Statistics: an update on the 2019 report from the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations. [PDF]

Stroke Vasc Neurol, 2022
Wang YJ, Li ZX, Gu HQ, Zhai Y, Zhou Q, Jiang Y, Zhao XQ, Wang YL, Yang X, Wang CJ, Meng X, Li H, Liu LP, Jing J, Wu J, Xu AD, Dong Q, Wang D, Wang WZ, Ma XD, Zhao JZ, China Stroke Statistics Writing Committee.   +21 more
europepmc   +1 more source